Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BSGM | US
0.00
0.22%
Healthcare
Medical Devices
30/06/2024
21/10/2024
0.50
0.50
0.51
0.45
BioSig Technologies Inc. together with its subsidiaries a medical device company commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies Inc. was incorporated in 2009 and is headquartered in Westport Connecticut.
View LessLow Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
290.9%1 month
229.8%3 months
175.1%6 months
224.7%-
-
36.58
-
-
-2.34
85.55
-
-18.38M
7.99M
7.99M
-
-40.71K
-
180.00
-6.34K
0.95
4.53
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.30
Range1M
0.30
Range3M
0.30
Rel. volume
0.70
Price X volume
11.61K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| INBS | INBS | Medical Devices | 1.5 | 6.37M | -4.46% | n/a | 10.46% |
| Sharps Technology Inc. | STSS | Medical Instruments & Supplies | 3.07 | 5.53M | 6.23% | n/a | 0.00% |
| Acutus Medical Inc | AFIB | Medical Devices | 0.16 | 5.20M | 9.22% | n/a | -745.93% |
| Reflect Scientific Inc | RSCF | Medical Instruments & Supplies | 0.0535 | 4.55M | 6.15% | n/a | 0.00% |
| Predictive Oncology Inc | POAI | Medical Instruments & Supplies | 0.6642 | 4.43M | -1.91% | n/a | 65.94% |
| NUWE | NUWE | Medical Devices | 1.95 | 3.64M | 31.76% | n/a | -9.57% |
| Sonendo Inc. | SONX | Medical Devices | 0.0492 | 3.58M | -1.60% | n/a | 0.00% |
| Common Stock | VERO | Medical Devices | 0.4633 | 3.36M | -3.28% | n/a | 1351.51% |
| INVO Bioscience Inc | INVO | Medical Devices | 0.833 | 3.25M | -2.91% | 1.24 | 394.32% |
| Talis Biomedical Corporation Common Stock | TLIS | Medical Devices | 1.69 | 2.81M | -8.65% | n/a | 38.66% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| MDJM Ltd | MDJH | Real Estate Services | 0.5604 | 8.75M | -10.66% | n/a | 0.00% |
| La Rosa Holdings Corp. Common Stock | LRHC | Real Estate Services | 0.485 | 8.64M | -3.00% | n/a | 76.18% |
| LuxUrban Hotels Inc. | LUXH | Real Estate Services | 0.0576 | 7.95M | 2.13% | n/a | -406.05% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5263 | 7.69M | -2.17% | 0.03 | 16.03% |
| ALBT | ALBT | Real Estate Services | 0.2 | 3.20M | 11.11% | n/a | 187.39% |
| DigitalBridge Group Inc. | DBRG-PJ | Real Estate Services | 24.81 | 0 | -0.68% | n/a | 17.23% |
| DigitalBridge Group Inc. | DBRG-PI | Real Estate Services | 25.03 | 0 | -0.36% | n/a | 17.23% |
| DigitalBridge Group Inc. | DBRG-PH | Real Estate Services | 25.07 | 0 | -0.04% | n/a | 17.23% |
| Common Stock | BPYPO | Real Estate Services | 16.52 | 0 | -1.49% | 7.64 | 866.10% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.34 | - | Cheaper |
| Ent. to Revenue | 85.55 | - | Expensive |
| PE Ratio | - | 30.41 | - |
| Price to Book | 36.58 | 6.21 | Expensive |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 175.11 | - | Riskier |
| Debt to Equity | - | -145.53 | - |
| Debt to Assets | - | 0.35 | - |
| Market Cap | 7.99M | - | Emerging |